Literature DB >> 27584589

Advances in prevention and treatment of vancomycin-resistant Enterococcus infection.

Heather Isenman1, Dale Fisher.   

Abstract

PURPOSE OF REVIEW: This article reviews data, particularly from the last 2 years, addressing the prevention and treatment of vancomycin-resistant Enterococcus (VRE). We focus on infection control, particularly active screening, use of contact precautions as well as pharmacologic options for therapy. This is timely given the evolving priorities in efforts towards the prevention and treatment of multidrug-resistant organisms globally. RECENT
FINDINGS: Key findings include new data regarding the impact of contact precautions on the incidence of VRE colonization and bloodstream infection, new laboratory screening methods, and novel decolonization strategies and treatments.
SUMMARY: Additional and specific measures beyond standard precautions for infection prevention of VRE remain controversial. Horizontal measures such as chlorhexidine bathing appear beneficial, as are nontouch environmental cleaning methods. Treatment options for invasive disease have improved considerably in the last decade. Decolonization strategies require further research. Overall, the threat of VRE seems exaggerated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27584589     DOI: 10.1097/QCO.0000000000000311

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  2 in total

1.  Factorial design and post-antibiotic sub-MIC effects of linezolid combined with fosfomycin against vancomycin-resistant enterococci.

Authors:  Yisong Yan; Guang Yang; Yaowen Li; Jun Mao; Shuaishuai Wang; Na Zhang; Huiping Liu; Xiaohui Huang
Journal:  Ann Transl Med       Date:  2022-02

2.  An orally administered drug prevents selection for antibiotic-resistant bacteria in the gut during daptomycin therapy.

Authors:  Valerie J Morley; Derek G Sim; Aline Penkevich; Robert J Woods; Andrew F Read
Journal:  Evol Med Public Health       Date:  2022-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.